Akari TherapeuticsAKTX
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 10 institutions reported holding Akari Therapeutics PLC (AKTX) in their 13F filings, unchanged from Q2 2024. 2 opened new positions and 2 sold out. The largest holders were Omnia Family Wealth, LLC ($259K), Citadel Advisors ($99K) and Cerity Partners LLC ($70K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Akari Therapeutics PLC
- CUSIP
- 00972G207
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $99K |
| Exits | 2 | $91K |
All 13F filers, Q2 2024 → Q3 2024: 34,312 shares bought and 33,179 shares sold, net +1,133 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Omnia Family Wealth, LLC | 0.11% | No change | 87,628 | $259K |
| Citadel Advisors | 0.00% | New | 33,260 | $99K |
| Cerity Partners LLC | 0.00% | No change | 23,643 | $70K |
| Cresset Asset Management, LLC | 0.00% | No change | 18,408 | $54K |
| Renaissance Technologies | 0.00% | Add +5.9% | 18,069 | $53K |
| Bank of America Corp. | 0.00% | No change | 150 | $442 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $295 |
| Truvestments Capital LLC | 0.00% | New | 50 | $148 |
| Morgan Stanley | 0.00% | Add +33.3% | 8 | $24 |
| Cornerstone Planning Group LLC | 0.00% | No change | 5 | $13 |
"% of holder's portfolio" is AKTX's weight in each manager's 13F, not the share of Akari Therapeutics PLC the manager owns.